** Shares of robotic surgery technology firm Intuitive Surgical ISRG.O inch 2.2% higher to $461.19 premarket
** Co's first-quarter revenue came in at $2.77 billion, beating analysts' estimates of $2.61 billion, as per data compiled by LSEG
** First-quarter adj. EPS of $2.50 beat expectations of $2.10
** Procedure volume growth, including 16% growth for company's da Vinci and 39% for Ion, drove higher revenue
** The average recommendation of 35 analysts is a "buy"; the median price target is $601.54 - LSEG-compiled data
** Stock trades at about 44 times forward 12-month earnings, compared with its five-year average of around 55
** Shares are down 20%, YTD
(Reporting by Purvi Agarwal in Bengaluru)
((Purvi.Agarwal@thomsonreuters.com;))